Filing Details

Accession Number:
0000891293-11-000005
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-02-24 19:18:28
Reporting Period:
2011-02-22
Filing Date:
2011-02-24
Accepted Time:
2011-02-24 19:18:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
891293 Cell Therapeutics Inc CTIC Pharmaceutical Preparations (2834) 911533912
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1201041 L Richard Love 501 Elliott Ave W.
Suite 400
Seattle WA 98119
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2011-02-22 900 $0.29 2,301,873 No 4 S Direct
Common Stock Disposition 2011-02-22 5,101 $0.29 2,296,772 No 4 S Direct
Common Stock Disposition 2011-02-22 7,200 $0.29 2,289,572 No 4 S Direct
Common Stock Disposition 2011-02-22 10,336 $0.30 2,279,236 No 4 S Direct
Common Stock Disposition 2011-02-22 5,400 $0.30 2,273,836 No 4 S Direct
Common Stock Disposition 2011-02-22 7,600 $0.30 2,266,236 No 4 S Direct
Common Stock Disposition 2011-02-22 5,578 $0.30 2,260,658 No 4 S Direct
Common Stock Disposition 2011-02-22 3,539 $0.30 2,257,119 No 4 S Direct
Common Stock Disposition 2011-02-22 2,000 $0.30 2,255,119 No 4 S Direct
Common Stock Disposition 2011-02-22 7,000 $0.30 2,248,119 No 4 S Direct
Common Stock Disposition 2011-02-22 8,446 $0.30 2,239,673 No 4 S Direct
Common Stock Disposition 2011-02-22 1,900 $0.30 2,237,773 No 4 S Direct
Common Stock Disposition 2011-02-22 3,600 $0.30 2,234,173 No 4 S Direct
Common Stock Disposition 2011-02-22 3,700 $0.31 2,230,473 No 4 S Direct
Common Stock Disposition 2011-02-22 300 $0.31 2,230,173 No 4 S Direct
Common Stock Disposition 2011-02-22 100 $0.31 2,230,073 No 4 S Direct
Common Stock Disposition 2011-02-22 800 $0.31 2,229,273 No 4 S Direct
Common Stock Disposition 2011-02-22 300 $0.31 2,228,973 No 4 S Direct
Common Stock Disposition 2011-02-22 1,200 $0.32 2,227,773 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.